About Therabel
Therabel is a Healthcare company based in Breda (Netherlands) founded in 1945, and was acquired by AFT Pharmaceuticals in May 2017. Pharmaceutical products are provided through industry partnerships for distribution. Therabel has completed 1 acquisition, including Javelin Pharmaceuticals. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Therabel was founded in 1945 and is headquartered in Breda, Netherlands. Operations are centered in the pharmaceutical sector, where partnerships with other companies are utilized to develop and distribute prescription and over-the-counter medications. A collaborative model is employed, drawing on shared expertise in regulatory affairs, supply chain management, sales, marketing, and finance. Experience has been gained by the management team across international markets.
- Headquarters Breda, Netherlands
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website therabel.com
- Social LinkedIn
- Acquired by AFT Pharmaceuticals (May 2017)
- Investors
- Investments & Acquisitions
- Acquired byAFT Pharmaceuticals
(May 2017)
Investors in Therabel
Therabel has secured backing from 1 investor. Prominent investors backing the company include AFT Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Proprietary and in-licensed pharmaceutical products are developed and distributed. | 1997 | aftpharm.com | Auckland, New Zealand |
Investor details for Therabel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Therabel
Therabel has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Javelin Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Novel drugs and formulations for pain disorders are developed. | javelinpharmaceuticals.com | Cambridge, United States | 1998 | Jun 2009 | •••• |
Complete acquisition details for Therabel
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Therabel
3 dated milestones of Therabel across 72 years, from founding to its latest funding, stage changes and deals.
- Founded Therabel is founded.
- Acquisition Acquires Javelin Pharmaceuticals.
- Exit Acquired by AFT Pharmaceuticals.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Therabel
Therabel was founded in 1945.
Therabel is headquartered in Breda, Netherlands. It is registered at Breda, Noord-brabant, Netherlands.
Therabel was founded in 1945 and is headquartered in Breda, Netherlands. Operations are centered in the pharmaceutical sector, where partnerships with other companies are utilized to develop and distribute prescription and over-the-counter medications. A collaborative model is employed, drawing on shared expertise in regulatory affairs, supply chain management, sales, marketing, and finance. Experience has been gained by the management team across international markets.
Therabel has made 1 acquisition, including Javelin Pharmaceuticals.
Therabel has 1 investor. Key investors include AFT Pharmaceuticals.
Yes. Therabel was acquired by AFT Pharmaceuticals in May 2017.